Corinne Kyler

The council members conducted roll call, introductions, and discussed the council's purpose and ground rules. The discussion focused on establishing strategic focus areas for the next one to three years, setting a charter and scope for the council's work, and understanding the legislative intent behind the council's creation. The council also addressed financial limitations and the need for guidance regarding the council's role in supporting state Rare Disease efforts.

The council meeting focused on reviewing the provisions of HB 943 and discussing best practices aligned with NORD RDAC. Members conducted a group reflection on the strengths and challenges regarding rare disease advocacy, followed by a mini-SWOT analysis categorized by community engagement, policy, and provider education. The meeting concluded with the development of a draft priority list and a rapid priority voting process.

The Montana Early Childhood Account's Eligible Uses & Investment Framework outlines five key investment categories: Provider Support & Workforce Development, Quality Improvement Initiatives, Affordability Initiatives, Innovation Initiatives, and Emergency Assistance & Disaster Relief. It details the strategic allocation of funds, differentiating between one-time capital investments and ongoing expenditures, and emphasizes principles of Board stewardship including supplementing existing funding, considering public data, representing all stakeholders, and data-driven prioritization based on Montana's Early Childhood Strategic Plan. The framework aims to build durable system capacity within early childhood infrastructure.

This document outlines a three-step Funding Decision Framework for the Montana Early Childhood Account (MECA) Board. The framework guides the evaluation of funding opportunities to ensure alignment with legislative intent, MECA's strategic priorities, and desired outcomes for Montana's early childhood system. Key steps include eligibility screening against the MECA Strategic Plan and authorizing legislation, investment assessment considering desired outcomes such as improved service access and quality, workforce development, and systems improvement, and a final board recommendation.

The meeting agenda includes a follow-up discussion on a SWOT analysis, a review of the council's structure and demographic representation, and an exploration of patient and policy perspectives regarding systemic issues in rare disease care. The meeting will also cover leadership and governance topics, followed by the determination of next steps and assignments.